(AFP / MANILA BULLETIN)
In a joint statement Wednesday night, May 6, HPAAC said claims by supporters that Ivermectin is effective and safe from side effects remain based on “low quality evidence.”
Citing a report by the Philippine Society for Microbiology and Infectious Diseases (PSMID), HPAAC reiterated that “there is no strong, conclusive evidence to recommend Ivermectin” to COVID-19 patients.
In April, the Food and Drug Administration (FDA) granted special permits to six hospitals to use the anti-parasitic drug on COVID-19 patients.
However, according to HPAAC, the permit “does not include the distribution of said medication outside of these hospitals.”
This after Anakalusugan Party-list Rep. Mike Defensor and Sagip Party-list Rep. Rodante Marcoleta distributed Ivermectin capsules to residents of Quezon City last week.